NEW ORLEANS -- Large-bore mechanical thrombectomy for high-risk pulmonary embolism (PE) was associated with fewer major adverse outcomes than other approaches, the FLAME study showed. Clot removal ...

IRVINE, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Compared with other treatment options and historical data, large-bore mechanical thrombectomy ...

IRVINE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...

Inari Medical, Inc. (NARI) was founded in 2011 and is based in Irvine, California. The company is focused on treating venous thromboembolism by thrombectomy. The currently approved thrombectomy ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Large-bore mechanical thrombectomy for pulmonary ...

Six month outcomes from the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) registry were presented today as late-breaking clinical research at the Society for ...

IRVINE, Calif., Oct. 24, 2017 /PRNewswire/ -- Inari Medical, Inc., a privately held venture backed medical device company dedicated to the development of innovative catheter-based technologies for the ...

Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices MARLBOROUGH, Mass., Oct. 24, 2023 /PRNewswire/ -- Data ...